| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expense) | 49 | 953 | 5,370 | -321 |
| Loss before income taxes | -8,489 | -6,847 | -3,095 | -44,222 |
| Provision for income taxes | 14 | 10 | 7 | 24 |
| Net loss | -8,503 | -6,857 | -3,102 | -44,246 |
| Net loss per share, basic (in dollars per share) | -1.59 | -1.99 | -1.15 | -0.52 |
| Net loss per share, diluted (in dollars per share) | -1.59 | -1.99 | -1.15 | -0.52 |
| Weighted-average common shares outstanding, basic (in shares) | 5,338,000 | 3,441,000 | 2,694,000 | 85,870,000 |
| Weighted-average common shares outstanding, diluted (in shares) | 5,338,000 | 3,441,000 | 2,694,000 | 85,870,000 |
Bionano Genomics, Inc. (BNGO)
Bionano Genomics, Inc. (BNGO)